Explore opportunities

Search by company name (Bolden, Pax, OncoLux, Nabsys), asset id, or title. Each card links to a full dossier with cited evidence.

Loading filters…

Tier Aip_wireless_neurograins
Wireless neurograins & distributed cortical implants

DARPA-scale wireless neurograins—dense cortical sensing without Utah-array tethers.

Brown OTL spinout after ~$19M DARPA + UH2—hardware path parallel to BrainGate decode IP.

Patents: 8Stage: preclinical human path
US10433754B2US11464964B2WO2016187254A1WO2020018571A1US20200367749A1US20200229704A1
Open dossier
Tier Aip_speech_tablet_ibci
Speech decoding & multi-device tablet iBCI

Recruiting speech and tablet iBCI trials—decode IP distinct from electrode vendors.

U01 + VA funding with NCT05724173 family—consortium license or device co-development.

Entity: BrainGatePatents: 6Stage: clinical trials recruiting
US12042303US11972050US12561001US10448877B2US18946156U01DC017844
Open dossier
Tier Aip_spinal_isi_dbs
Intelligent spinal interface & closed-loop DBS facilitation

DARPA intelligent spinal interface—SCI rehab IDE distinct from cortical BCI.

DARPA $6.3M + NCT04302259—medtech strategic or SPV vs wireless neurograins.

Patents: 2Stage: early clinical ide
WO2019027517A1US20170042713A1I01RX004250NCT04302259
Open dossier
Tier Aip_bolden_musk_neurogenesis
MuSK-pathway ASO neurogenesis (Bolden Therapeutics)

ASO switch for neural stem-cell quiescence—Brown Fallon/Webb science in a Slater-backed Providence newco.

NIA STTR + $1.5M pre-seed (Slater, Lifespan Vision)—formation capital before Big Pharma neurogenesis comparables.

Entity: Bolden TherapeuticsPatents: 3Stage: preclinical in vivo
US12458657B2US20220193114A1WO20200214987A1Source
Open dossier
Tier APatent gapgap_ni2o_kiwi_bci
KIWI wireless micro-implant BCI (ni2o)

KIWI wireless micro-implant BCI—Providence HQ with BrainGate FTO diligence.

Nurosene partnership + strategic path—harvest Howard/ni2o USPTO vs Brown patents.

Entity: ni2oPatents: 3Stage: preclinical grant
US20260137929A1US20210196980A1US20210263589A1
Open dossier
Research synthesis from public sources (NIH RePORTER, ClinicalTrials.gov, PubMed, USPTO, company press). Not investment advice, legal opinion, or clinical guidance. Verify cap tables, license chains, and trial status in data rooms before term sheets.